Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

Challenges associated with the development and design of neoantigen cancer vaccines.

Antibody fragment discovery could lead to much-needed treatment for light chain amyloidosis

In people with a rare condition called light chain amyloidosis, light chain proteins-;which are a component of antibodies-;mutate and build up in different organs.

July 10, 2024

How Trump, RFK Jr. could influence biopharma; Viking presents weight loss data; Are MASH drugs getting boxed out by GLP-1s?; and more

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 10, 2024

J&J unveils PhIIa data of oral antiviral for dengue fever prevention

Johnson & Johnson’s oral antiviral has shown hints of activity in a Phase IIa human challenge trial for the prevention of mosquito-borne disease dengue fever,

October 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.